Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Dolores Mahmud, PhD, Shrihari S. Kadkol, MD PhD, Annie L. Oh, MD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4276.

https://doi.org/10.1182/blood.V128.22.4276.4276

Published: 2016

Journal Articles

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

Paolo Catarsi, Francesca Cordero, Giulio Ferrero, Marco Beccuti, Valentina Poletto, Elisa Bonetti, PhD, Laura Villani, Margherita Massa, Gabriela Fois, Rita Campanelli, Umberto Magrini, Vittorio Rosti, Giovanni Barosi

Blood (2016) 128 (22): 4279.

https://doi.org/10.1182/blood.V128.22.4279.4279

Published: 2016

Journal Articles

High Levels of High Sensitivity-C Reactive Protein (hs-CRP) Are Associated with Older Age, Chromosomal Abnormalities and JAK2V617F Mutation with High Allele Burden in Primary Myelofibrosis (PMF)

Giovanni Barosi, Margherita Massa, Gabriela Fois, Rita Campanelli, Elisa Bonetti, PhD, Valentina Poletto, Laura Villani, Paolo Catarsi, Vittorio Rosti

Blood (2016) 128 (22): 1956.

https://doi.org/10.1182/blood.V128.22.1956.1956

Published: 2016

Journal Articles

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Margherita Massa, Rita Campanelli, Gabriela Fois, Laura Villani, Elisa Bonetti, Paolo Catarsi, Valentina Poletto, Gianluca Viarengo, Mara De Amici, Vittorio Rosti, Robert Peter Gale, Giovanni Barosi

Blood (2016) 128 (12): 1660–1662.

https://doi.org/10.1182/blood-2016-03-704577

Published: 2016

Includes: Supplemental data

Journal Articles

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

Margherita Massa, PhD, Rita Campanelli, BS, Gabriela Fois, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Gianluca Viarengo, MD, Vittorio Rosti, MD, Giovanni Barosi, MD

Blood (2015) 126 (23): 2809.

https://doi.org/10.1182/blood.V126.23.2809.2809

Published: 2015

Journal Articles

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Laura Villani, BS,, Rita Campanelli, BS, Gabriella Gaudioso, BS, Valentina Poletto, PhD, Elisa Bonetti, PhD, Paolo Catarsi, BS, Gabriela Fois, BS, Benedetta G Erba, PhD, Margherita Massa, PhD, Umberto Magrini, MD, Giovanni Barosi, MD, Umberto Gianelli, MD, Vittorio Rosti, MD

Blood (2015) 126 (23): 2833.

https://doi.org/10.1182/blood.V126.23.2833.2833

Published: 2015

Journal Articles

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Annie L. Oh, MD, Dolores Mahmud, PhD, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Nadim Mahmud, MD PhD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2015) 126 (23): 4271.

https://doi.org/10.1182/blood.V126.23.4271.4271

Published: 2015

Journal Articles

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

Rita Campanelli, BS, Gabriela Fois, BS, Carlotta Abbà, BS, Mara De Amici, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Giovanni Barosi, MD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2015) 126 (23): 1639.

https://doi.org/10.1182/blood.V126.23.1639.1639

Published: 2015

Journal Articles

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Giovanni Barosi, MD, Valentina Poletto, Biol Sci, Elisa Bonetti, BS, Laura Villani, Biol Sci, Paolo Catarsi, PhD, Gianluca Viarengo, MD, Rita Campanelli, Biol. Sci, Margherita Massa, PhD, Vittorio Rosti, MD

Blood (2014) 124 (21): 3191.

https://doi.org/10.1182/blood.V124.21.3191.3191

Published: 2014

Journal Articles

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Blood (2014) 124 (21): 3227.

https://doi.org/10.1182/blood.V124.21.3227.3227

Published: 2014

Journal Articles

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Annie L. Oh, MD, Dolores Mahmud, Ph.D., Benedetta Nicolini, Ph.D., Nadim Mahmud, MD, PhD, Elisa Bonetti, BS, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2013) 122 (21): 1999.

https://doi.org/10.1182/blood.V122.21.1999.1999

Published: 2013

Journal Articles

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Giovanni Barosi, MD, Rita Campanelli, Biol. Sci, Gabriela Fois, Biol. Sci, Valentina Poletto, Biol. Sci, Laura Villani, Biol. Sci, Elisa Bonetti, BS, Paolo Catarsi, PhD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2013) 122 (21): 4057.

https://doi.org/10.1182/blood.V122.21.4057.4057

Published: 2013

Journal Articles

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Giovanni Barosi, MD, Elisa Bonetti, BS, Paolo Catarsi, PhD, Margherita Massa, PhD, Rita Campanelli, Biol.Sci, Valentina Poletto, Biol.Sci, Gianluca Viarengo, MD, Laura Villani, Biol.Sci, Gabriela Fois, Biol.Sci, Flavia Biamonte, BiSci, PhD, Giada Rotunno, BiSci, Paola Guglielmelli, PhD MD, Umberto Magrini, MD, Alessandro M Vannucchi, MD, Vittorio Rosti, MD

Blood (2013) 122 (21): 4058.

https://doi.org/10.1182/blood.V122.21.4058.4058

Published: 2013

Journal Articles

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

Blood (2013) 121 (2): 360–368.

https://doi.org/10.1182/blood-2012-01-404889

Published: 2013

Includes: Supplemental data

Journal Articles

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.

Giovanni Barosi, MD, Valentina Poletto, Biol Sci, Margherita Massa, Ph D, Rita Campanelli, Biol. Sci, Laura Villani, Biol Sci, Elisa Bonetti, Biol Sci, Gianluca Viarengo, MD, Paolo Catarsi, PhD, Catherine Klersy, MD, Vittorio Rosti, MD

Blood (2012) 120 (21): 2829.

https://doi.org/10.1182/blood.V120.21.2829.2829

Published: 2012

Journal Articles

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

Paolo Catarsi, PhD, Vittorio Rosti, MD, Vittorio Abbonante, BS, Alessandra Balduini, MD, Gaetano Bergamaschi, MD, Elisa Bonetti, Biol Sci, Valentina Poletto, Biol Sci, Laura Villani, Biol Sci, Giovanni Barosi, MD

Blood (2011) 118 (21): 3844.

https://doi.org/10.1182/blood.V118.21.3844.3844

Published: 2011

Journal Articles

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Vittorio Rosti, MD, Elisa Bonetti, Gaetano Bergamaschi, MD, Rita Campanelli, PhD, Elisabetta Gattoni, MD, Sonia Lo Po, Umberto Magrini, MD, Margherita Massa, PhD, Alessandro Vannucchi, MD, Gianluca Viarengo, MD, Paola Guglielmelli, MD, Massimo Primignani, MD, Giovanni Barosi, MD

Blood (2009) 114 (22): 309.

https://doi.org/10.1182/blood.V114.22.309.309

Published: 2009

Journal Articles

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Blood (2009) 114 (14): 3127–3130.

https://doi.org/10.1182/blood-2008-12-190991

Published: 2009

Journal Articles

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

Rita Campanelli, PhD, Margherita Massa, PhD, Elisa Bonetti, Gianluca Viarengo, MD, Vittorio Rosti, MD, Elisabetta Gattoni, MD, Enza Moretti, Gaetano Bergamaschi, MD, Laura Villani, PhD, Marco Lucioni, MD, Laura Bandiera, MD, Roberta Riboni, PhD, Gianni Barosi, MD

Blood (2008) 112 (11): 3725.

https://doi.org/10.1182/blood.V112.11.3725.3725

Published: 2008

Journal Articles

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Elisa Bonetti, Vittorio Rosti, MD, Laura Villani, PhD, Rita Campanelli, PhD, Gaetano Bergamaschi, MD, Margherita Massa, PhD, Alessandro Pecci, MD, Alessandro M. Vannucchi, MD, Francesco Frassoni, MD, Giovanni Barosi, MD

Blood (2007) 110 (11): 1535.

https://doi.org/10.1182/blood.V110.11.1535.1535

Published: 2007

NARROW

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

High Levels of High Sensitivity-C Reactive Protein (hs-CRP) Are Associated with Older Age, Chromosomal Abnormalities and JAK2V617F Mutation with High Allele Burden in Primary Myelofibrosis (PMF)

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only